250 mg 250 mg Pill - orange capsule/oblong
Pill with imprint 250 mg 250 mg is Orange, Capsule/Oblong and has been identified as Erythromycin Delayed Release 250 mg. It is supplied by Dr. Reddy's Laboratories, Inc.
Erythromycin is used in the treatment of Bronchitis; Bacterial Endocarditis Prevention; Bowel Preparation; Bartonellosis; Bullous Pemphigoid and belongs to the drug class macrolides. There is no proven risk in humans during pregnancy. Erythromycin 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 250 mg 250 mg
Erythromycin Delayed Release
- Imprint
- 250 mg 250 mg
- Strength
- 250 mg
- Color
- Orange (orange transparent body and orange opaque cap)
- Shape
- Capsule/Oblong (capsule containing white enteric-coated pellets)
- Availability
- Prescription only
- Drug Class
- Macrolides
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Dr. Reddy's Laboratories, Inc.
- National Drug Code (NDC)
- 75907-0076
Related images for "250 mg 250 mg"
More about erythromycin
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (67)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Support group
- Drug class: macrolides
- Breastfeeding
- En español
Patient resources
Other brands
Erythrocin, Ery-Tab, E.E.S. Granules, Eryc, ... +4 more
Professional resources
- Erythromycin monograph
- Erythromycin Ethylsuccinate (AHFS Monograph)
- Erythromycin Lactobionate (AHFS Monograph)
- Erythromycin Stearate (AHFS Monograph)
- Erythromycins General Statement (AHFS Monograph)
Other brands
Erythrocin, Ery-Tab, E.E.S. Granules, EryPed, PCE Dispertab
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.